68
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Neuropathic Pain and Chemotherapy-Induced Peripheral Neurotoxicity: The Issue

, , , &
Pages 417-419 | Published online: 07 Nov 2013

References

  • Caraceni A , HanksG, KaasaS et al. Use of opioid analgesic in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 13 , 58–68 (2012).
  • Vadalouca A , RaptisE, MokaE et al. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Practice 12 , 219–251 (2012).
  • Argyriou AA , BrunaJ, MarmiroliP, CavalettiG. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit. Rev. Oncol. Hematol.82 , 51–77 (2012).
  • Cavaletti G , FrigeniB, LanzaniF et al. Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur. J. Cancer 46 , 479–494 (2010).
  • Cavaletti G , CornblathD, MerkiesI et al. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann. Oncol. 24 , 454–462 (2013).
  • Cavaletti G , FrigeniB, LanzaniF et al. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J. Peripher. Nerv. Syst. 12 , 210–215 (2007).
  • Cornblath DR , ChaudhryV, CarterK et al. Total neuropathy score: validation and reliability study. Neurology 53 , 1660–1664 (1999).
  • Breivik H , CollettB, VentafriddaV et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain 10(4) , 287–333 (2006).
  • Bouhassira D , AttalN, FermanianJ et al. Development and validation of the neuropathic pain symptom inventory. Pain 108 , 248–257 (2004).
  • Cruccu G , SommerC, AnandP et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur. J. Neurol. 17 , 1010–1018 (2010).
  • Spallone V , MorgantiR, D‘AmatoC et al. Validation of DN4 as a screening tool for neuropathic pain. Diabet. Med. 29 , 578–585 (2012).
  • Attal N , CruccuG, BaronR et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 17 , 1113–1123 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.